Sangamo Therapeutics Inc (NASDAQ:SGMO) price closed higher on Monday, April 15, jumping 2.15% above its previous close.
A look at the daily price movement shows that the last close reads $0.54. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.80 and 52-week low of $0.29. The stock subtracted -28.83% on its value in the past month.
Sangamo Therapeutics Inc, which has a market valuation of $113.06 million. Analysts tracking SGMO have forecast the quarterly EPS to shrink by -0.21 per share this quarter, while the same analysts predict the annual EPS to hit -$0.5 for the year 2024 and up to -$0.27 for 2025. In this case, analysts estimate an annual EPS growth of 66.20% for the year and 46.00% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $6.65 million, with the likely lows of $2 million and highs of $11.3 million. The average estimate suggests sales growth for the quarter will likely fall by -95.80% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $45.88 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow -74.00% below that which the company brought in 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with — upward and — downward reviews. On the technical perspective front, indicators give SGMO a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that SGMO’s price is at present -15.29% off the SMA20 and -30.39% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 39.50, with weekly volatility standing at 8.57%. The indicator jumps to 12.39% when calculated based on the past 30 days. Sangamo Therapeutics Inc (NASDAQ:SGMO)’s beta value is holding at 1.38, while the average true range (ATR) indicator is currently reading 0.08.
An analysis of the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock in terms of its daily trading volume indicates that the 3-month average is 2.39 million.
Current records show that the company has 203.67M in outstanding shares. The insiders’ percentage holdings are 10.07% of outstanding shares while the percentage share held by institutions stands at 49.19%. But the 2.17% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
